Cardiac Science Corp (MM) (NASDAQ:CSCX)
Historical Stock Chart
5 Years : From Feb 2012 to Feb 2017
Faruqi & Faruqi, LLP, a leading national securities firm headquartered
in New York City, is investigating the Board of Directors of Cardiac
Science Corporation (“Cardiac Science” or the “Company”) (NASDAQ: CSCX)
for potential breaches of fiduciary duties in connection with their
conduct related to the sale of the Company to Opto Circuits Limited. The
proposed transaction offers Cardiac Science shareholders to only receive
$2.30 per share in cash. The transaction is structured as a tender offer
which may obviate the need for a shareholder vote. According to Thomson/First
Call, at least one financial analyst values Cardiac Science’ common
stock at $6.00 per share.
Request more information now by clicking here: www.faruqilaw.com/cscx
Whether the Cardiac Science’s Board of Directors breached their
fiduciary duties to Cardiac Science’s stockholders by failing to conduct
an adequate and fair sales process to sell the Company prior to agreeing
to this proposed transaction, whether the proposed transaction
undervalues Cardiac Science’s shares and by how much this proposed
transaction undervalues the Company to the detriment of Cardiac Science
shareholders are the key focus of this investigation.
Faruqi & Faruqi, LLP is a national law firm which represents investors
and individuals in class action litigation. The firm is focused on
providing exemplary legal services in complex litigation in the areas of
securities, shareholder, antitrust and consumer litigation, through all
phases of litigation. The firm has an experienced trial team which has
achieved significant victories on behalf of the firm’s clients.
If you own common stock in Cardiac Science and wish to obtain additional
information, please visit us at www.faruqilaw.com/cscx
or contact Juan E. Monteverde, Esq. either via e-mail at [email protected]
or by telephone at (877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law firm
responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com).
Prior results do not guarantee or predict a similar outcome with respect
to any future matter. We are happy to discuss your particular case.